Kymera Therapeutics Announces First Quarter 2022 Financial Results and Provides a Business Update

Go back to Kymera Therapeutics Announces First Quarter 2022 Financial Results and Provides a Business Update
(NASDAQ: KYMR) Delayed: 90.43 +0.53 (0.59%)
Previous Close $89.90    52 Week High
Open $90.68    52 Week Low
Day High $92.47    P/E N/A 
Day Low $89.18    EPS
Volume 1,262,295